The effect of a hemicholinium analogue, HC-15, of neuromuscular transmission.
D000109:Acetylcholine / Q000096:biosynthesis; D000818:Animals; D001001:Anura; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D002415:Cats; D002794:Choline / Q000378:metabolism; D002800:Cholinesterase Inhibitors; D006168:Guinea Pigs; D006426:Hemicholinium 3 / Q000378:metabolism / Q000494:pharmacology*; D009025:Morpholines / Q000378:metabolism / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000201:enzymology / Q000378:metabolism; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D009025:Morpholines; D006426:Hemicholinium 3; D009388:Neostigmine; D010830:Physostigmine; D002794:Choline; D000109:Acetylcholine